Home » Topics » BioWorld Science

BioWorld Science
RSS

Phage-based nanoligands wrap up drugs for delivery across BBB

Oct. 25, 2019

Circular RNA hsa_circ_0006848 identified as a potential diagnostic biomarker of early gastric cancer

Oct. 25, 2019

Heterozygous COL4A1 mutations are a potential autosomal dominant cause of CAKUT

Oct. 25, 2019

Hypertensive rats are more sensitive to TRPM8-mediated relaxation of the pudendal artery

Oct. 25, 2019

Flavonoid baicalin upregulates miR-126-5p: a potential therapeutic strategy against atherosclerosis

Oct. 25, 2019

Anti-influenza drug candidate targeting the hemagglutinin stalk of influenza viruses

Oct. 25, 2019

FDA approves Zejula and companion diagnostic for late-line ovarian cancer

Oct. 24, 2019

LIDDS reports data from OLE study of Liproca depot in prostate cancer

Oct. 24, 2019

New phase II trial studies suvorexant for comorbid sleep disorder and alcohol dependence

Oct. 24, 2019

FDA clears BlueWillow's IND for anthrax vaccine candidate BW-1010

Oct. 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...